Abstract

While a certain level of inflammation is critical for humans to survive infection and injury, a prolonged inflammatory response can have fatal consequences. Pattern recognition Toll-like receptors (TLRs) are key players in the initiation of an inflammatory process. TLR2 is one of the most studied pattern recognition receptors (PRRs) and is known to form heterodimers with either TLR1, TLR4, TLR6, and TLR10, allowing it to recognize a wide range of pathogens. Although a large number of studies have been conducted over the past decades, there are still many unanswered questions regarding TLR2 mechanisms in health and disease. In this review, we provide an up-to-date overview of TLR2, including its homo- and heterodimers. Furthermore, we will discuss the pro- and anti-inflammatory properties of TLR2 and recent findings in prominent TLR2-associated infectious and neurodegenerative diseases.

MeSH

Infections, Toll-Like Receptors, Toll-Like Receptor 2

Cited by

• The updated evidence of pirfenidone treated silicosis based on network pharmacology, molecular docking and experimental validation. Front Med (Lausanne), 2025
• Advances in Genetic Polymorphism Research in Rosacea: Mechanisms and Clinical Implications. Clin Cosmet Investig Dermatol, 2025
• Activation of toll-like receptor 2 promotes the expression of inflammatory mediators and cell proliferation of human polycystic kidney disease cells. Cell Signal, 2025
• Fucosylated Glycosaminoglycan Oligosaccharide HS14, Derived from Sea Cucumbers, Is a Novel Inhibitor of Platelet Toll-like Receptor 2. Mar Drugs, 2025
• Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review. Front Immunol, 2024
• Toll-like Receptor Type 2 and 13 Gene Expression and Immune Cell Profiles in Diploid and Triploid Sterlets (Acipenser ruthenus): Insights into Immune Competence in Polyploid Fish. Int J Mol Sci, 2025
• Pulmonary toxicity assessment of polypropylene, polystyrene, and polyethylene microplastic fragments in mice. Toxicol Res, 2024
• Immunity and Coagulation in COVID-19. Int J Mol Sci, 2024
• An Immunoinformatic Approach for Identifying and Designing Conserved Multi-Epitope Vaccines for Coronaviruses. Biomedicines, 2024
• Proteomic Analysis of Signaling Pathways Modulated by Fatty Acid Binding Protein 5 (FABP5) in Macrophages. J Pharmacol Exp Ther, 2024
• Toll-like receptor 2 deficiency exacerbates corneal angiogenesis in injury by impairing regulatory T cells. Theranostics, 2025
• Gut microbiota-mediated pain sensitization: mechanisms and therapeutic implications. Front Pain Res (Lausanne), 2025
• TLR2 and TLR4 bridge physiological and pathological inflammation in the reproductive system. Commun Biol, 2025
• Pattern recognition receptors: function, regulation and therapeutic potential. Signal Transduct Target Ther, 2025